A cluster analysis demonstrated the potential for the Multiple Sleep Latency Test (MSLT) to aid in the diagnosis of central hypersomnia and distinguish between idiopathic hypersomnia subgroups. The ...
Alkermes announced today the initiation of the Brilliance Studies, a phase 3 program that will test the safety and efficacy ...
Please provide your email address to receive an email when new articles are posted on . Prolonged REM sleep latency was associated with three key Alzheimer’s-specific pathological changes. REM sleep ...
— Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statistically Significant Improvements from Baseline in Mean Sleep Latency Compared to Placebo at All Doses Tested — — ALKS ...
A new study has found a link between rapid eye movement (REM) sleep and Alzheimer’s disease. The research from China, published in the journal Alzheimer’s & Dementia by the Alzheimer’s Association, ...
A study investigating potential subtypes of idiopathic hypersomnia (IH) found that patients with IH who experience unrefreshing naps have less fragmented sleep compared with those who take refreshing ...
We conducted a phase 2, randomized, placebo-controlled trial of TAK-994, an oral orexin receptor 2–selective agonist, in patients with narcolepsy type 1. Patients with confirmed narcolepsy type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results